Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22214
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Naka, K. K. | en |
dc.contributor.author | Kalantaridou, S. N. | en |
dc.contributor.author | Bechlioulis, A. | en |
dc.contributor.author | Kravariti, M. | en |
dc.contributor.author | Kazakos, N. | en |
dc.contributor.author | Katsouras, C. S. | en |
dc.contributor.author | Tsatsoulis, A. | en |
dc.contributor.author | Michalis, L. K. | en |
dc.date.accessioned | 2015-11-24T19:22:57Z | - |
dc.date.available | 2015-11-24T19:22:57Z | - |
dc.identifier.issn | 1473-0766 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/22214 | - |
dc.rights | Default Licence | - |
dc.subject | Adolescent | en |
dc.subject | Adult | en |
dc.subject | Androgen Antagonists/pharmacology/*therapeutic use | en |
dc.subject | Cyproterone Acetate/pharmacology/*therapeutic use | en |
dc.subject | Drug Therapy, Combination | en |
dc.subject | Estrogens/pharmacology/*therapeutic use | en |
dc.subject | Ethinyl Estradiol/pharmacology/*therapeutic use | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Pilot Projects | en |
dc.subject | Polycystic Ovary Syndrome/*drug therapy | en |
dc.subject | Prospective Studies | en |
dc.subject | Regression Analysis | en |
dc.subject | Vasodilation/*drug effects | en |
dc.subject | Young Adult | en |
dc.title | Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | 10.3109/09513590.2010.521265 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21329419 | - |
heal.identifier.secondary | http://informahealthcare.com/doi/abs/10.3109/09513590.2010.521265 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2011 | - |
heal.abstract | BACKGROUND: Combined oral contraceptives are used in polycystic ovary syndrome (PCOS) women for the treatment of hyperandrogenism and menstrual cycle disturbances. AIM: To assess the effect of ethinylestradiol and cyproterone acetate (EE/CA) on endothelial function in young, non-obese PCOS women in a pilot study. METHODS: Thirteen young, non-obese PCOS women (20.9 +/- 3.7 years, 23.0 +/- 4.0 kg/m(2)) received 35 mcg EE & 2 mg CA for 6 months. Fourteen age- and body mass index (BMI)-matched healthy women served as controls. Endothelial function assessed by brachial artery flow-mediated dilation (FMD), indices of hyperandrogenism, and insulin resistance were studied at baseline and 6-month follow-up. RESULTS: FMD was impaired in PCOS compared to control women (4.67 +/- 2.38% vs. 10.12 +/- 3.19%, p < 0.001), but increased significantly following EE/CA (9.99 +/- 2.11%, p < 0.001 vs. baseline), reaching normal values (p = NS vs. controls). EE/CA also significantly decreased hyperandrogenism indices and increased total and HDL cholesterol and triglycerides (p < 0.05 vs. baseline). The only independent predictor of treatment-induced FMD improvement in PCOS women was the decrease in free androgen index. CONCLUSIONS: Treatment with combination of estrogens and antiandrogens reverses endothelial dysfunction in young, non-obese PCOS women mainly via improving hyperandrogenism. Further research is needed to investigate whether this treatment may also reduce cardiovascular risk in these women. | en |
heal.journalName | Gynecol Endocrinol | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License